Atorvastatin and Fluvastatin Potentiate Blood Pressure Lowering Effect of Amlodipine through Vasorelaxant Phenomenon

Medicina (Kaunas). 2023 May 25;59(6):1023. doi: 10.3390/medicina59061023.

Abstract

Background and Objectives: We have recently reported that stains have calcium channel blocking activity in isolated jejunal preparations. In this study, we examined the effects of atorvastatin and fluvastatin on blood vessels for a possible vasorelaxant effect. We also studied the possible additional vasorelaxant effect of atorvastatin and fluvastatin, in the presence of amlodipine, to quantify its effects on the systolic blood pressure of experimental animals. Materials and Methods: Atorvastatin and fluvastatin were tested in isolated rabbits' aortic strip preparations using 80mM Potassium Chloride (KCl) induced contractions and 1 micro molar Norepinephrine (NE) induced contractions. A positive relaxing effect on 80 mM KCl induced contractions were further confirmed in the absence and presence of atorvastatin and fluvastatin by constructing calcium concentration response curves (CCRCs) while using verapamil as a standard calcium channel blocker. In another series of experiments, hypertension was induced in Wistar rats and different test concentrations of atorvastatin and fluvastatin were administered in their respective EC50 values to the test animals. A fall in their systolic blood pressure was noted using amlodipine as a standard vasorelaxant drug. Results: The results show that fluvastatin is more potent than amlodipine as it relaxed NE induced contractions where the amplitude reached 10% of its control in denuded aortae. Atorvastatin relaxed KCL induced contractions with an amplitude reaching 34.4% of control response as compared to the amlodipine response, i.e., 39.1%. A right shift in the EC50 (Log Ca++ M) of Calcium Concentration Response Curves (CCRCs) implies that statins have calcium channel blocking activity. A right shift in the EC50 of fluvastatin with relatively less EC50 value (-2.8 Log Ca++ M) in the presence of test concentration (1.2 × 10-7 M) of fluvastatin implies that fluvastatin is more potent than atorvastatin. The shift in EC50 resembles the shift of Verapamil, a standard calcium channel blocker (-1.41 Log Ca++ M). Conclusions: Atorvastatin and fluvastatin relax the aortic strip preparations predominantly through the inhibition of voltage gated calcium channels in high molar KCL induced contractions. These statins also inhibit the effects of NE induced contractions. The study also confirms that atorvastatin and fluvastatin potentiate blood pressure lowering effects in hypertensive rats.

Keywords: amlodipine; atorvastatin; calcium channel blocking activity; fluvastatin; statins; verapamil.

MeSH terms

  • Amlodipine / pharmacology
  • Amlodipine / therapeutic use
  • Animals
  • Atorvastatin / pharmacology
  • Atorvastatin / therapeutic use
  • Blood Pressure
  • Calcium
  • Calcium Channel Blockers* / pharmacology
  • Calcium Channel Blockers* / therapeutic use
  • Calcium Channels / pharmacology
  • Fluvastatin / pharmacology
  • Fluvastatin / therapeutic use
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Potassium Chloride / pharmacology
  • Rabbits
  • Rats
  • Rats, Wistar
  • Vasodilator Agents / pharmacology
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Atorvastatin
  • Fluvastatin
  • Vasodilator Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Amlodipine
  • Calcium
  • Verapamil
  • Calcium Channels
  • Potassium Chloride

Grants and funding

The authors extend their appreciation to the deanship of scientific research at Shaqra University for funding this research work through the project number (SU-ANN-202201).